Terri B Hyde
Affiliation: Centers for Disease Control and Prevention
- The impact of new vaccine introduction on immunization and health systems: a review of the published literatureTerri B Hyde
Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Vaccine 30:6347-58. 2012..Future evaluations of new vaccine introductions should include the systematic and objective assessment of the impacts on a country's immunization system and broader health system, especially in lower-income countries...
- Critical issues in implementing a national integrated all-vaccine preventable disease surveillance systemTerri B Hyde
Global Immunization Division, Us centers for Disease Control and Prevention CDC, 1600 Clifton Road NE, Atlanta, GA 30333, USA
Vaccine 31:C94-8. 2013..We describe the process of developing operational guidance for ministries of health to implement such an integrated surveillance system for multiple VPDs...
- Measles outbreak in the Republic of the Marshall Islands, 2003Terri B Hyde
Viral Vaccine Preventable Diseases Branch, National Immunization Program, NIP, Centers for Disease Control and Prevention, CDC, Atlanta, GA 30333, USA
Int J Epidemiol 35:299-306. 2006..Reported 1-dose measles vaccine coverage among children aged 12-23 months varied widely (52-94%) between 1990 and 2000...
- Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?Terri B Hyde
National Center for Immunization and Respiratory Diseases proposed, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Clin Infect Dis 43:S146-50. 2006..8% to 88.0%; P=.84). In 1999-2004, population rubella immunity levels were at or above the modeled threshold for elimination of rubella virus transmission. Increases in immunity levels are consistent with vaccination efforts...
- Laboratory confirmation of measles in elimination settings: experience from the Republic of the Marshall Islands, 2003Terri B Hyde
Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, United States of America
Bull World Health Organ 87:93-8. 2009....
- Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individualsCarole J Hickman
Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 204:S549-58. 2011..These parameters may represent useful biomarkers for classification of SVF cases that previously could not be confirmed as such using routine laboratory diagnostic techniques...
- Review of cytomegalovirus seroprevalence and demographic characteristics associated with infectionMichael J Cannon
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention CDC, Atlanta, GA 30329, USA
Rev Med Virol 20:202-13. 2010..Future vaccine or educational campaigns to prevent primary infection in pregnant women may need to be tailored to suit the needs of different populations...
- Seroprevalence of measles antibody in the US population, 1999-2004Geraldine M McQuillan
Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, MD 20782, USA
J Infect Dis 196:1459-64. 2007..Testing for measles antibody was included in the National Health and Nutrition Examination Survey (NHANES), a nationally representative survey, conducted during 1999-2004...
- Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infectionMichael J Cannon
National Center on Birth Defects and Developmental Disabilities, Atlanta, GA, USA
Rev Med Virol 21:240-55. 2011..Higher CMV viral load at birth also consistently correlated with the presence of symptoms of congenital CMV at birth. Published 2011. This article is a US Government work and is in the public domain in the USA...
- Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan childrenSarah Y Park
From the Office of Workforce and Career Development, Centers for Disease Control and Prevention CDC, Atlanta, GA, USA
Pediatr Infect Dis J 27:335-40. 2008..The impact of heptavalent pneumococcal conjugate vaccine (PCV7) on transmission of antimicrobial-resistant Streptococcus pneumoniae is an important concern for countries considering PCV7 introduction...
- Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in AlaskaMatthew R Moore
Division of Applied Public Health Training, Epidemiology Program Office, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
J Infect Dis 190:2031-8. 2004..Antimicrobial resistance among pneumococci has increased in recent years and complicates treatment. The introduction of heptavalent pneumococcal conjugate vaccine (PCV7) could reduce acquisition of antimicrobial-resistant pneumococci...
- Integrating pneumonia prevention and treatment interventions with immunization services in resource-poor countriesAdam L Cohen
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Bull World Health Organ 90:289-94. 2012....
- Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMVTerri B Hyde
National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention CDC, Atlanta, GA 30329, USA
Rev Med Virol 20:311-26. 2010..The relatively low rate of CMV seroconversion in most populations is encouraging for behavioural interventions and for vaccine strategies attempting to prevent infection during pregnancy...
- Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011Kashmira A Date
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Emerg Infect Dis 17:2105-12. 2011..Use of OCVs is an option for cholera control; guidelines for their appropriate use in epidemic and emergency settings are urgently needed...
- Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and AtlantaTerri B Hyde
Active Bacterial Core surveillance of the Emerging Infections Program Network, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Pediatrics 110:690-5. 2002..The objective of this study was to determine trends in the incidence of early-onset sepsis caused by organisms other than group B streptococcus in the era of antimicrobial prophylaxis...
- Coronavirus antibodies in bat biologistsLauren J Stockman
Emerg Infect Dis 14:999-1000. 2008